More accessible diabetes treatment with 2nd generation insulin

Share this information:

There are about 3.7 million diabetic Filipinos at present, which is seen to double in the next five years.

However, only about 34 percent are actually diagnosed, 27 percent are getting treatment, while only 11 percent are on insulin and lower than 50 percent can manage or control their disease.

Especially in this time of the COVID-19 pandemic, managing diabetes poses a challenge for Filipinos. As more cases are recorded on a daily basis, vigilance is important for people with lifestyle diseases like diabetes, which means adhering to maintenance medication and treatment.

Thus, in time for the 100th year anniversary of Insulin, Sanofi Philippines is committed to build a healthier Philippines by making diabetes management easier and more accessible to Filipinos. Dr. Amal Makhloufi, Country Lead of Sanofi Philippines, said “We are committed to improving the health of Filipinos and we are taking all possible steps to make innovative health solutions and diabetes care more accessible and even more affordable for the second generation insulins,” Dr. Makhloufi replied to

Through its widely accessible insulin products and programs that are focused on patient care and coaching, Sanofi, according to Dr. Makhloufi, is fully committed to be the health journey partner of Filipinos.

The Second Generation insulins were introduced to the market as a better and more accessible option for patients with diabetes. These are made more readily available in pharmacies and hospitals, as well as through online and delivery services in order to cater to the needs of a broader base of patients.

Sanofi Philippines, Dr. Makhloufi averred, continues to improve patient access to diabetes treatment with the newest insulin at an affordable price, enhance patient life through the Empower program, where continuous care and coaching is provided to patients by doctors and diabetes educators.

She also noted that they are in constant partnership with several stakeholders from the health and education sector to further promote diabetes management. The company is also working with Ayala Healthcare Holdings Inc. (AC Health) to promote a more holistic approach to patient care by properly educating patients on their disease, empowering them to create informed decisions about their care, making them more confident in managing their conditions.

Sanofi Philippines also launched KiDS (Kids and Diabetes in Schools) and Youth Health Patrol, with support from the Department of Education, University of Asia and the Pacific, and APB Foundation, to help educate the youth about the benefits of living a healthier lifestyle.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Next Post

DOH: RT-PCR test, epektibo pa rin sa pagtukoy ng COVID-19

Sat Apr 17 , 2021
Tiniyak kahapon ng Department of Health (DOH) na nananatili pa ring epektibo sa pagtukoy ng COVID-19 ang Reverse Transcription-Polymerase Chain Reaction (RT-PCR) test na ikinukonsidera pa din bilang gold standard sa COVID-19 testing. Ang pagtiyak ay ginawa ni Health Undersecretary Maria Rosario Vergeire kasunod ng ilang naglabasang concern na isang […]

Follow Us

%d bloggers like this: